Form 4: Madrigal Pharmaceuticals Executive Waltermire Exercises Options and Sells Shares
SEC Form 4 Filing
Robert E. Waltermire, Senior VP of Madrigal Pharmaceuticals, exercised stock options and sold 2,000 shares of common stock on June 12, 2024.
Summary
- On June 12, 2024, Robert E. Waltermire, Senior VP of Madrigal Pharmaceuticals, exercised stock options to acquire 2,000 shares of common stock at a price of $87.92 per share.
- Simultaneously, Waltermire sold 2,000 shares of common stock at $285 per share.
- Following these transactions, Waltermire directly owns 5,500 shares of Madrigal Pharmaceuticals common stock.
- Waltermire also holds options to purchase 15,200 shares of common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 08/02/2022 | 25% of the shares underlying the option vested. |
| 06/12/2024 | Date of transaction: Waltermire exercised options and sold shares. |
| 06/14/2024 | Date of filing of the SEC Form 4. |
| 08/02/2031 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.